With regard to the government's decision to extend the interval between certain COVID-19 vaccines by up to 105 days: (a) what assessment has the government made on the impact of this decision of those who are suffering from cancer; and (b) what is the government's response to concerns raised by a study from King's College London and the Francis Crick Institute, which found that delays in administering the second dose of more than 21 days leave cancer patients vulnerable to COVID-19?
In the House of Commons on May 10th, 2021. See this statement in context.